Device Trial Radar · NCT06620419
Clinical Study of External Electrical Stimulation for Male Incontinence
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
37
Actual
Start
Jun 11, 2024
Primary completion
Jan 30, 2026
Study completion Feb 28, 2026
Sponsor
- Lead sponsor
- Elidah, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 1, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to evaluate the effectiveness of the Elidah neuromuscular stimulation treatment to reduce incontinence in men post-prostatectomy.
Conditions
- Urinary Incontinence
Interventions
Perineal-applied electrical stimulationDevice
Small controller that outputs stimulation for stress incontinence and OAB, attached to a male-anatomy thin GelPad placed in the perineal area.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 24-Hour Urine Leakage Measured by Pad WeightTime frame: 6 weeks
- 24-Hour Urine Leakage Measured by Pad WeightTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Elidah
Monroe, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.